CN103751548A - Chinese medicinal preparation for treating senile depression - Google Patents

Chinese medicinal preparation for treating senile depression Download PDF

Info

Publication number
CN103751548A
CN103751548A CN201410033230.8A CN201410033230A CN103751548A CN 103751548 A CN103751548 A CN 103751548A CN 201410033230 A CN201410033230 A CN 201410033230A CN 103751548 A CN103751548 A CN 103751548A
Authority
CN
China
Prior art keywords
parts
herba
folium
radix
depression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410033230.8A
Other languages
Chinese (zh)
Other versions
CN103751548B (en
Inventor
颜淑环
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410033230.8A priority Critical patent/CN103751548B/en
Publication of CN103751548A publication Critical patent/CN103751548A/en
Application granted granted Critical
Publication of CN103751548B publication Critical patent/CN103751548B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a Chinese medicinal preparation for treating senile depression, which is prepared from the following raw materials: Abelmoschus moschatus, Epipactis yunnanensis, Eriosema himalaicum, Tarenna mollissima, Microsorium buergerianum, Stellariza yunnanensis, Asparagus setaceus, Styrax obassia, Viola japonica, Comanthosphace ingpoensis, Selaginella doederleinii, Herba Inulae Cappae, Gaura lindheimeri, Orchis, Pilea cadierei, Broussonetia kaempfer, Limonium sinense and Broussonetia kazinoki. The Chinese medicinal preparation for treating senile depression provided by the invention has reasonable formulation and definite effect, and can be used for effectively treating senile depression.

Description

A kind of medicament for the treatment of depression in old age
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of depression in old age.
Background technology
Depression in old age refers to that First episode is after 60 years old, a kind of mental disorder take lasting depressive mood as main clinical manifestation, there is obvious depressed syndrome, how with various Chronic Somatic Diseases, in addition each tract, because Age-related regression declines to the ability of resisting psychic trauma, more easily brings out.
Summary of the invention
The object of this invention is to provide a kind of medicament for the treatment of depression in old age.
In order to realize object of the present invention, the invention provides a kind of medicament for the treatment of depression in old age, it is to be made by weight by following bulk drugs: Radix seu folium abelmoschi moschati 5-30 part, Radix epipactinis 5-30 part, Eriosema himalaicum Ohashi 5-30 part, Folium seu Fructus Tarennae 5-30 part, flag 10-20 part, Radix Stellariae Yunnanensis 10-20 part, Herba Asparagi Setacei 10-20 part, Fructus Styracis obassiae 10-20 part, Herba Violae japonicae 1-10 part, Herba Elsholtziae Ciliatae 1-10 part, Herba Selaginellae Doederleinii 1-10 part, Herba Inulae cappae 1-10 part, white butterfly flower 1-10 part, Herba Orchidis Latifoliae 1-5 part, pilea cadierei 1-5 part, paddy skin rattan 1-5 part, Herba Limonii Gmelinii 1-5 part and a Folium et Cacumen Broussonetiae Kazinoki 1-5 part.
Preferably, the medicament for the treatment of depression in old age of the present invention is to be made by weight by following bulk drugs: 18 parts of Radix seu folium abelmoschi moschatis, 18 parts of Radix epipactinis, 16 parts of Eriosema himalaicum Ohashis, 11 parts, 15 parts, one flag of Folium seu Fructus Tarennae, 12 parts of Radix Stellariae Yunnanensiss, 12 parts of Herba Asparagi Setaceis, 11 parts of Fructus Styracis obassiaes, 9 parts of Herba Violae japonicaes, 9 parts of Herba Elsholtziae Ciliataes, 8 parts of Herba Selaginellae Doederleiniis, 8 parts of Herba Inulae cappaes, white butterfly are spent 2 parts of 8 parts, 3 parts of Herba Orchidis Latifoliae, 3 parts of pilea cadiereis, 3 parts, paddy skin rattan, 2 parts of Herba Limonii Gmelinii and Folium et Cacumen Broussonetiae Kazinoki.
More preferably, described medicament can be tablet, dispersible tablet, disintegrating tablet, instant, enteric coatel tablets, capsule or decoction.
In compositions of the present invention, Radix seu folium abelmoschi moschati, Radix epipactinis, Eriosema himalaicum Ohashi, Folium seu Fructus Tarennae are monarch drug; Flag, Radix Stellariae Yunnanensis, Herba Asparagi Setacei, a Fructus Styracis obassiae are ministerial drug; Herba Violae japonicae, Herba Elsholtziae Ciliatae, Herba Selaginellae Doederleinii, Herba Inulae cappae, white butterfly flower are adjuvant drug; Herba Orchidis Latifoliae, pilea cadierei, paddy skin rattan, Herba Limonii Gmelinii and Folium et Cacumen Broussonetiae Kazinoki are for making medicine, and various composition performance synergism are to produce optimum efficiency.
In order to understand better the present invention, with reference to < < Chinese medicine voluminous dictionary > > second edition (Shanghai science tech publishing house, 2005) explanation of some crude drug that, use in the present invention sees the following form:
Figure BDA0000461223260000021
Figure BDA0000461223260000031
The drug prescription for the treatment of depression in old age of the present invention is reasonable, and effect is clear and definite, can effectively treat depression in old age.
The specific embodiment
Below by embodiment, further illustrate the present invention.It should be understood that embodiments of the invention are for the present invention rather than limitation of the present invention are described.The simple modifications that essence according to the present invention is carried out the present invention all belongs to the scope of protection of present invention.Except as otherwise noted, the percent otherwise in the present invention is percetage by weight.
Embodiment decoction of the present invention
Get 18 grams of Radix seu folium abelmoschi moschatis, 18 grams of Radix epipactinis, 16 grams of Eriosema himalaicum Ohashis, 11 grams, 15 grams, one flag of Folium seu Fructus Tarennae, 12 grams of Radix Stellariae Yunnanensiss, 12 grams of Herba Asparagi Setaceis, 11 grams of Fructus Styracis obassiaes, 9 grams of Herba Violae japonicaes, 9 grams of Herba Elsholtziae Ciliataes, 8 grams of Herba Selaginellae Doederleiniis, 8 grams of Herba Inulae cappaes, white butterfly and spend 2 grams of 8 grams, 3 grams of Herba Orchidis Latifoliae, 3 grams of pilea cadiereis, 3 grams, paddy skin rattan, 2 grams of Herba Limonii Gmelinii and Folium et Cacumen Broussonetiae Kazinoki, add 15000 milliliters, water, in the flask that condenser is housed, at 80 ℃, heat 5 hours, filter, filtrate is decoction of the present invention.
Experimental example
Physical data
Selection meets patient's 60 examples of inclusive criteria, is this Out-patient Department and inpatient, by medical order, is divided into matched group 30 examples, treatment group 30 examples.Treatment group: male 15 examples, female's 15 examples, 63.2 years old mean age, average course of disease 2.3 years; Matched group: male 15 examples, female's 15 examples, 64.1 years old mean age, average course of disease 2.4 years.Above 2 groups of every and Syndrome Types of TCMs, medical situation, Epidemiological Analysis difference not statistically significant (P>0.05), has comparability by statistics.
Inclusive criteria
Western medicine diagnose: all meet < < Chinese Spirit Obstacles classification and diagnostic criteria > > the 3rd edition (CCMD-3) (psychiatric department branch of Chinese Medical Association Chinese Spirit Obstacles classification and diagnostic criteria (CCMD-3) [S]. Jinan: Shandong science tech publishing house, 2001; 4. diagnostic criteria).Tcm diagnosis standard with reference to the differentiation of symptoms and signs for classification of syndrome of the melancholia in < < Chinese Internal Medicine > > (Zhou Zhongying chief editor. Chinese Internal Medicine [M] .7 version. Beijing: China Traditional Chinese Medicine Publishing House, 2003:392-397.).Hamilton depressive scale (HAMD >=17 point).Brink senile depression scale (DGS >=11 point.Male or female, the course of disease is more than 1 year, and the age is more than 60 years old.Inactive various antidepressant before treatment, get rid of apparatus factors and cause depressive state.
The decoction making in the oral embodiment for the treatment of group is treated, and one day 2 times, each oral 200 milliliters, treats continuously 3 months.
The oral deanxit sheet of matched group (Denmark Ling Bei pharmaceutical Co. Ltd), sooner or later respectively take 1 every day, treats continuously 3 months.
Curative effect determinate standard
With reference to < < traditional Chinese medical science disease Standardization of diagnosis and curative effect > > (State Administration of Traditional Chinese Medicine. traditional Chinese medical science disease Standardization of diagnosis and curative effect (S) Nanjing: publishing house of Nanjing University, 1994; 20.).Cure: mental state and emotion are normal, and interest increases, resourceful, normally, somatization disappears, and can adapt to daily life work completely for diet, sleep.Effective: mental state and emotion are clearly better, anxiety reduces, and self evaluation increases, and diet, sleep normal, can adapt to daily life substantially.Invalid: symptom is not improved.
Result
Therapeutic outcome through two groups of treatments sees the following form:
Group Number of cases Cure Effectively Invalid Total effective rate (%)
Treatment group 30 21 8 1 96.67
Matched group 30 10 15 5 83.33
Untoward reaction
There are 2 routine xerostomia cases in matched group, 1 example headache case, the nauseating case of 1 example.Treatment group has no untoward reaction.
Model case
Zhang, female, 62 years old, retired government functionary.Depressed, impatient, insomnia, everything is lost interest in, and givees free rein to fancy more than 2 years, and thoughts of suicide is strong.Taking antidepressant drug can not tolerate, and subjective symptoms increases the weight of, in Lai Wo institute treatment January 8 in 2013.The decoction making in oral embodiment is treated, and one day 2 times, each oral 200 milliliters, treats continuously 3 months.Symptom disappears substantially, and mental state and emotion are normal, and interest increases, resourceful, and normally, somatization disappears, and can adapt to daily life work completely for diet, sleep.Effect of follow-up visit by telephone has no recurrence half a year.
Liu, female, 65 years old, retired secondary school teachers.Depressed, can't be happy, during sad melancholy wish cry, life enthusiasm interest decline, companion impatiently insomnia, fatigue and weak, time have thoughts of suicide more than 2 years.In Lai Wo institute treatment February 15 in 2013.The decoction making in oral embodiment is treated, and one day 2 times, each oral 200 milliliters, treats continuously 3 months.Symptom disappears substantially, and mental state and emotion are normal, and interest increases, resourceful, and normally, somatization disappears, and can adapt to daily life work completely for diet, sleep.Effect of follow-up visit by telephone has no recurrence half a year.
Ma, man, 63 years old, peasant.Depressed, like sulkyly, occupied with nothing all day, short-tempered, accompany vexed bitter taste, inappetence, fatigue and weak, accompanies vexed insomnia, and lethargy is depressed, retardation of thinking, sensation Working Life is without any meaning, and companion's thoughts of suicide frequently waits a year and a half to have a surplus.In Lai Wo institute treatment January 29 in 2013.The decoction making in oral embodiment is treated, and one day 2 times, each oral 200 milliliters, treats continuously 3 months.Symptom disappears substantially, and mental state and emotion are normal, and interest increases, resourceful, and normally, somatization disappears, and can adapt to daily life work completely for diet, sleep.Effect of follow-up visit by telephone has no recurrence half a year.

Claims (3)

1. treat the medicament of depression in old age for one kind, it is characterized in that, it is to be made by weight by following bulk drugs: Radix seu folium abelmoschi moschati 5-30 part, Radix epipactinis 5-30 part, Eriosema himalaicum Ohashi 5-30 part, Folium seu Fructus Tarennae 5-30 part, flag 10-20 part, Radix Stellariae Yunnanensis 10-20 part, Herba Asparagi Setacei 10-20 part, Fructus Styracis obassiae 10-20 part, Herba Violae japonicae 1-10 part, Herba Elsholtziae Ciliatae 1-10 part, Herba Selaginellae Doederleinii 1-10 part, Herba Inulae cappae 1-10 part, white butterfly flower 1-10 part, Herba Orchidis Latifoliae 1-5 part, pilea cadierei 1-5 part, paddy skin rattan 1-5 part, Herba Limonii Gmelinii 1-5 part and a Folium et Cacumen Broussonetiae Kazinoki 1-5 part.
2. the medicament for the treatment of depression in old age according to claim 1, it is characterized in that, it is to be made by weight by following bulk drugs: 18 parts of Radix seu folium abelmoschi moschatis, 18 parts of Radix epipactinis, 16 parts of Eriosema himalaicum Ohashis, 11 parts, 15 parts, one flag of Folium seu Fructus Tarennae, 12 parts of Radix Stellariae Yunnanensiss, 12 parts of Herba Asparagi Setaceis, 11 parts of Fructus Styracis obassiaes, 9 parts of Herba Violae japonicaes, 9 parts of Herba Elsholtziae Ciliataes, 8 parts of Herba Selaginellae Doederleiniis, 8 parts of Herba Inulae cappaes, white butterfly are spent 2 parts of 8 parts, 3 parts of Herba Orchidis Latifoliae, 3 parts of pilea cadiereis, 3 parts, paddy skin rattan, 2 parts of Herba Limonii Gmelinii and Folium et Cacumen Broussonetiae Kazinoki.
3. the medicament for the treatment of depression in old age according to claim 1 and 2, is characterized in that, described medicament can be tablet, dispersible tablet, disintegrating tablet, instant, enteric coatel tablets, capsule or decoction.
CN201410033230.8A 2014-01-24 2014-01-24 A kind of medicament for the treatment of depression in old age Expired - Fee Related CN103751548B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410033230.8A CN103751548B (en) 2014-01-24 2014-01-24 A kind of medicament for the treatment of depression in old age

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410033230.8A CN103751548B (en) 2014-01-24 2014-01-24 A kind of medicament for the treatment of depression in old age

Publications (2)

Publication Number Publication Date
CN103751548A true CN103751548A (en) 2014-04-30
CN103751548B CN103751548B (en) 2015-11-25

Family

ID=50518975

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410033230.8A Expired - Fee Related CN103751548B (en) 2014-01-24 2014-01-24 A kind of medicament for the treatment of depression in old age

Country Status (1)

Country Link
CN (1) CN103751548B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1277852A (en) * 2000-06-14 2000-12-27 邓开仲 Pharmaceutical for preventing and treating senile dementia and depression, and its prepn. process
CN1895477A (en) * 2006-06-14 2007-01-17 广州汉方现代中药研究开发有限公司 Antidespressant and its preparation
CN101607036A (en) * 2008-06-20 2009-12-23 河北以岭医药研究院有限公司 The application of a kind of Chinese medicine composition in the medicine of preparation treatment depression
CN103495044A (en) * 2006-11-14 2014-01-08 王选民 Pure traditional Chinese medicine preparation for treating neurosis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1277852A (en) * 2000-06-14 2000-12-27 邓开仲 Pharmaceutical for preventing and treating senile dementia and depression, and its prepn. process
CN1895477A (en) * 2006-06-14 2007-01-17 广州汉方现代中药研究开发有限公司 Antidespressant and its preparation
CN103495044A (en) * 2006-11-14 2014-01-08 王选民 Pure traditional Chinese medicine preparation for treating neurosis
CN101607036A (en) * 2008-06-20 2009-12-23 河北以岭医药研究院有限公司 The application of a kind of Chinese medicine composition in the medicine of preparation treatment depression

Also Published As

Publication number Publication date
CN103751548B (en) 2015-11-25

Similar Documents

Publication Publication Date Title
WO2013071727A1 (en) Anti-tumor traditional chinese medical composition
CN107913305B (en) Prunella vulgaris extract and preparation method and application thereof
CN101856370A (en) Medicine combination capable of regulating immunity
CN104706881B (en) A kind of health products with regulation sleep function
CN102961578A (en) Traditional Chinese medicine health care product for improving sleep and preparation method thereof
CN103751548B (en) A kind of medicament for the treatment of depression in old age
CN101862354A (en) Pharmaceutical composition for adjusting immunity
CN103877376B (en) A kind of pharmaceutical preparation treating depression
CN101653573A (en) Traditional Chinese medicine preparation for treating insomnia
CN102688477B (en) Medicinal composition for treating respiratory diseases of livestock
CN104623382A (en) Traditional Chinese medicine for treating insomnia caused by internal disturbance due to phlegm heat
CN103463154B (en) The application in preparation treatment Menieres disease medicine of total secondary ginseng glycoside composition, Radix Ginseng prosapogenin or ginseng raw saponin
CN102100729B (en) Oral administration medicament for treating and preventing radiation damage
CN110934908A (en) Compound nutritional health product capable of increasing body temperature to prevent diseases
CN101019980B (en) Health product for improving sleep quality
CN104147168B (en) A kind of Chinese medicine for treating pressure ulcer
CN104740148B (en) A kind of Chinese medicine composition and preparation method thereof for treating post-stroke depression
CN103735850B (en) A kind of medicament for the treatment of dentin hypersensitiveness
CN102670817A (en) Medicament for treating various blood diseases such as thrombocytopenia, purpura and leukaemia
CN107753628A (en) A kind of Chinese medicine composition and preparation method for treating insomnia
CN100591343C (en) Medicine for treating lung cancer and preparation technology thereof
CN102552790B (en) Medicament for stopping vomit after radiography
Sewda et al. A double-blind, placebo-controlled, randomized clinical trial to evaluate the efficacy and safety of Virulina® along with standard treatment as per hospital protocol for the treatment of novel coronavirus (COVID-19)
CN102961725B (en) Agentia for treating dysthymia
CN103919959A (en) Use of carex baccans extract in preparation of drug for removing stasis and relieving pain

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20151125

Termination date: 20170124

CF01 Termination of patent right due to non-payment of annual fee